Neuroimmunomodulation in Major Depressive Disorder: Focus on Caspase 1, Inducible Nitric Oxide Synthase, and Interferon-Gamma
Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and its incidence is expected to increase. Despite tremendous efforts to understand its underlying biological mechanisms, MDD pathophysiology remains elusive and pharmacotherapy outcomes are still far from ideal. L...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2019
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22620
- Acceso en línea:
- https://doi.org/10.1007/s12035-018-1359-3
https://repository.urosario.edu.co/handle/10336/22620
- Palabra clave:
- Amfebutamone
Berberine
Brain derived neurotrophic factor
Cytokine
Gamma interferon
Glucocorticoid
Inducible nitric oxide synthase
Interleukin 18
Interleukin 1alpha
Interleukin 1beta
Interleukin 1beta converting enzyme
Interleukin 33
Memantine
Neurotransmitter
Reactive oxygen metabolite
Venlafaxine
Gamma interferon
Inducible nitric oxide synthase
Interleukin 1beta converting enzyme
Antidepressant activity
Clinical study
Cytokine production
Cytokine response
Drug efficacy
Drug safety
Human
Immunomodulation
Innate immunity
Intestine flora
Intracellular signaling
Major depression
Mental disease
Nervous system inflammation
Neuropathology
Nitrosative stress
Nonhuman
Preclinical study
Protein synthesis inhibition
Remission
Review
Animal
Enzymology
Immunology
Major depression
Metabolism
Microbiology
Animals
Caspase 1
Gastrointestinal microbiome
Humans
Interferon-gamma
Neuroimmunomodulation
Nitric oxide synthase type ii
Caspase 1
Gut microbiome
Inducible nitric oxide synthase
Inflammasome
Inflammation
Interferon gamma
Interleukin 1
Major depressive disorder
Mdd
Neuroinflammation
T-helper 1 (th1)
major
Depressive disorder
- Rights
- License
- Abierto (Texto Completo)